Inovio Pharmaceuticals Statistics
Total Valuation
INO has a market cap or net worth of $80.86 million. The enterprise value is $8.50 million.
Important Dates
The next estimated earnings date is Wednesday, March 5, 2025, after market close.
| Earnings Date | Mar 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INO has 36.10 million shares outstanding. The number of shares has increased by 16.75% in one year.
| Current Share Class | 36.10M |
| Shares Outstanding | 36.10M |
| Shares Change (YoY) | +16.75% |
| Shares Change (QoQ) | +3.47% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 28.37% |
| Float | 32.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 279.13 |
| Forward PS | 242.62 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 41.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.17.
| Current Ratio | 3.88 |
| Quick Ratio | 3.69 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -263.84 |
Financial Efficiency
Return on equity (ROE) is -106.64% and return on invested capital (ROIC) is -59.76%.
| Return on Equity (ROE) | -106.64% |
| Return on Assets (ROA) | -50.56% |
| Return on Invested Capital (ROIC) | -59.76% |
| Return on Capital Employed (ROCE) | -145.29% |
| Revenue Per Employee | $1,667 |
| Profits Per Employee | -$925,214 |
| Employee Count | 122 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.58% in the last 52 weeks. The beta is 0.89, so INO's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -72.58% |
| 50-Day Moving Average | 2.18 |
| 200-Day Moving Average | 6.32 |
| Relative Strength Index (RSI) | 54.46 |
| Average Volume (20 Days) | 753,046 |
Short Selling Information
The latest short interest is 5.01 million, so 13.87% of the outstanding shares have been sold short.
| Short Interest | 5.01M |
| Short Previous Month | 4.89M |
| Short % of Shares Out | 13.87% |
| Short % of Float | 15.38% |
| Short Ratio (days to cover) | 4.40 |
Income Statement
In the last 12 months, INO had revenue of $203,413 and -$112.88 million in losses. Loss per share was -$4.45.
| Revenue | 203,413 |
| Gross Profit | -81.77M |
| Operating Income | -121.41M |
| Pretax Income | -121.64M |
| Net Income | -112.88M |
| EBITDA | -119.50M |
| EBIT | -121.41M |
| Loss Per Share | -$4.45 |
Full Income StatementBalance Sheet
The company has $84.80 million in cash and $12.45 million in debt, giving a net cash position of $72.36 million or $2.00 per share.
| Cash & Cash Equivalents | 84.80M |
| Total Debt | 12.45M |
| Net Cash | 72.36M |
| Net Cash Per Share | $2.00 |
| Equity (Book Value) | 73.54M |
| Book Value Per Share | 2.82 |
| Working Capital | 67.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$110.69 million and capital expenditures -$487,832, giving a free cash flow of -$111.18 million.
| Operating Cash Flow | -110.69M |
| Capital Expenditures | -487,832 |
| Free Cash Flow | -111.18M |
| FCF Per Share | -$3.08 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -59,685.24% |
| Pretax Margin | -55,491.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.75% |
| Shareholder Yield | -16.75% |
| Earnings Yield | -139.59% |
| FCF Yield | -137.49% |
Dividend DetailsAnalyst Forecast
The average price target for INO is $17.00, which is 658.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.00 |
| Price Target Difference | 658.93% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 158.14% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
INO has an Altman Z-Score of -21.81 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -21.81 |
| Piotroski F-Score | 1 |